WASHINGTON -- The maker of Tamiflu influenza medication estimated Tuesday that there could be a brief shortage of the oral suspension tablets this month, due to increased demand.

According to the U.S. Food and Drug Administration, Genentech, Inc. expects to have an additional supply of the tablets next week.

Read the FDA statement

Tamiflu is a prescription medicine used to treat people who have had flu symptoms for no more than two days. It can also reduce the chance of getting the flu.

During the shortage of oral suspension tablets, pediatric patients over 1 year of age can be dosed correctly using the 30 mg and 45 mg capsules, according to the FDA statement.

For those patients who cannot swallow capsules, the capsules can be opened and the contents may be mixed with chocolate syrup or some other thick, sweet liquid, as directed by a healthcare professional, the statement adds.

Click here for more on the flu, including alternatives to Tamiflu, from the Centers for Disease Control and Prevention.

Read or Share this story: